Steve Melvyn Howdle
Chairman at The University of Nottingham
Steve Melvyn Howdle active positions
| Companies | Position | Start | End |
|---|---|---|---|
| The University of Nottingham | Chairman | - | - |
Career history of Steve Melvyn Howdle
Former positions of Steve Melvyn Howdle
| Companies | Position | Start | End |
|---|---|---|---|
Critical Pharmaceuticals Ltd.
 Critical Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Critical Pharmaceuticals Ltd. operates as a clinical stage biotechnology company with interest in developing and producing biological drug products. The company product pipeline includes CP024: Nasal hGH, CP046: Nasal PTH, CP016: hGH Depot and CP018: Risperidone. Critical Pharmaceuticals was founded by Steve Howdle and Kevin Morris Shakesheff in 2002 and is headquartered in Nottingham, the United Kingdom. | Chief Tech/Sci/R&D Officer | 2001-12-31 | - |
| Founder | 2001-12-31 | - |
Statistics
International
| United Kingdom | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Chairman | 1 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Critical Pharmaceuticals Ltd.
Critical Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Critical Pharmaceuticals Ltd. operates as a clinical stage biotechnology company with interest in developing and producing biological drug products. The company product pipeline includes CP024: Nasal hGH, CP046: Nasal PTH, CP016: hGH Depot and CP018: Risperidone. Critical Pharmaceuticals was founded by Steve Howdle and Kevin Morris Shakesheff in 2002 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Steve Melvyn Howdle
- Experience
